Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SCMP > SEC Filings for SCMP > Form 8-K on 8-Nov-2012All Recent SEC Filings

Show all filings for SUCAMPO PHARMACEUTICALS, INC.

Form 8-K for SUCAMPO PHARMACEUTICALS, INC.


8-Nov-2012

Results of Operations and Financial Condition, Regulation FD Disclo


Item 2.02. Results of Operations and Financial Condition.

On November 8, 2012, Sucampo Pharmaceuticals, Inc. ("the Company") announced its consolidated financial results for the quarter ended September 30, 2012. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing.



Item 7.01. Regulation FD Disclosure.

On November 8, 2012, the Company will provide a corporate presentation update during the financial results webcast, which will include written communication, comprised of slides. The slides from the presentation are being furnished as Exhibit 99.2 to this Current Report on Form 8-K.

The information in this Item 7.01 and Exhibit 99.2 to this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.



Item 8.01. Other Events.

On November 2, 2012, the Company's Board of Directors authorized the increase in the repurchase of up to an aggregate of $5,000,000 from $2,000,000 of its class A common stock out of the $10,000,000 previously approved by the Board of Directors in December 2008. The repurchase program is expected to continue through to the third quarter of 2013 unless extended or shortened.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed:

99.1 Press Release issued by the registrant on November 8, 2012.
99.2 The corporate update presentation slides dated November 8, 2012.


  Add SCMP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SCMP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.